focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.60
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.939%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.60
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Dec 2013 07:00

RNS Number : 5658V
Allocate Software PLC
16 December 2013
 



16 December 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

First Half Trading Update

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, reports the following update for the six months ended 30 November 2013.

 

Allocate's performance in the first half year is in line with the Board's expectations, with total revenue, recurring revenue and pipeline growing versus the first half of the prior year, in what remains the seasonally slower period of our financial year.

 

Closing net cash has risen to £7.4m versus £2.1m at half year end of the prior year.

 

Healthroster continues to lead our business with a better than expected performance in the period. We secured an additional four new customers, including three new NHS Trusts taking the total to 154. These three wins included two competitive displacements. In addition, we renewed a further ten Healthroster term licence customers, bringing the total now to 43 and maintaining our 100% renewal rate.

 

The adoption of the Allocate Cloud continues to increase and is in line with our target of doubling the number of Cloud customers by the end of this financial year.

 

Our latest application, Safe Care, has been well received by NHS Trusts with a number of customers agreeing contracts in the period.

Our Patient Flow and Emergency Department business has not grown at the speed that management expected. Whilst the product has been well received by a number of potential customers, decision cycles are longer than expected.

Our Swedish business continues to perform ahead of management's plans and our Australia business has met expectations, in terms of results and also pipeline. Maritime and Defence had a first half focused primarily on business development activities, as expected.

 

We are pleased to have concluded the rationalisation of our London premises to a single head office and the relocation of our Swedish subsidiary's main office in the period. An exceptional cost will be recorded in the period in respect of these moves.

 

The Company's results for the half year to 30 November 2013 will be released on 20 January 2014.

 

Ian Bowles, Chief Executive Officer of Allocate, commented:

 

"The first half saw another solid performance from Allocate.

 

The demand for our productsremains healthy, particularly with respect to HealthRoster, the Allocate Cloud and Safe Care. We exited the half year with a larger pipeline for these solutions than we had at the beginning of this financial year and significantly stronger than at the same time last year.

 

The focus of the Secretary of State for Health, NHS England and the Care Quality Commission on safe staffing is a key driver of the increasing number of Trusts expressing interest in our solutions, particularly Safe Care.

 

I expect the positive trend we are seeing to continue through the second half of this year. The transition of our customer base onto V10 is a key requirement for growth in sales of Safe Care and Cloud and I am pleased to report that this program continues to be on track.

 

Although the timing of our licence and services revenues remains weighted to the latter part of the year, our strong product portfolio, sales pipeline and the improving quality of our revenue streams give us confidence in a strong second half performance."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel : +44 (0) 20 7831 3113

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOUWROAAUAAA
Date   Source Headline
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSNotice of Results
8th Jan 20137:00 amRNSFirst Half Trading Update
23rd Nov 20123:18 pmRNSResult of AGM
31st Oct 20127:00 amRNSBoard Appointment
29th Oct 20127:00 amRNSNotice of AGM
18th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:56 amRNSNotification of Major Interest in Shares
1st Oct 20121:14 pmRNSTrading Update
19th Sep 20124:01 pmRNSExercise of Options
15th Aug 20124:35 pmRNSGrant of Share Options to Directors
15th Aug 20127:05 amRNSAnnual Accounts 2012
13th Aug 20123:27 pmRNSNotification of Major Interest in Shares
13th Aug 201210:15 amRNSNotification of Major Interest in Shares
31st Jul 20127:05 amRNSRecord Final Results FYE 31 May 2012
31st Jul 20127:00 amRNSAcquisition of RealTime Health

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.